Conference call begins at 4:30 p.m. Eastern time today

BOCA RATON, Fla. , April 30, 2020 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 7, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2020. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT

Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06

BOCA RATON, Fla. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and year ended December 31, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

BOCA RATON, Fla, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it has shipped and installed a Sculptura™ radiation oncology system to Stanford Health Care in Palo Alto, Calif.  The system was shipped in December.  This is the third system to be shipped by Sensus and follows the sale of one system to Beilinson Hospital of the Rabin Medical Center in Israel and one to the University of Pennsylvania in Philadelphia. Sculptura received U.S. Food and Drug Administration 510(k) clearance in February 2019. 

New corporate structure positions company for 2020 financial goals

BOCA RATON, Fla., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December 5, 2019 at 8:30 a.m. Eastern time.  The conference will be held December 3-5, 2019 at the Lotte New York Palace Hotel in New York City.

Conference call begins at 4:30 p.m. Eastern time today

BOCA RATON, Fla., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter ended September 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

BOCA RATON, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2019.

BOCA RATON, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter ended June 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

BOCA RATON, Fla., June 10, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June 19 at 2:25 p.m. Eastern time.  The conference will be held June 18-19, 2019 at the Lotte New York Palace Hotel in New York City.

Management unable to present at Liolios Gateway conference due to Hurricane Irma

BOCA RATON, Fla., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San Francisco.

BOCA RATON, Fla., June 05, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, June 15th at 11:00 a.m. Eastern time. The conference will be held at the Grand Hyatt Hotel in New York City on June 15th and 16th.